GENE 0.8 (-27.93%)
SE0000661613Medical Diagnostics & ResearchDiagnostics & Research

Genetic Technologies (GENE) Competitor Comparison

We are evaluating the key criteria listed to compare Genetic Technologies (GENE) against its competitors in the Diagnostics & Research industry.

Linearity 10 years - GENE ranking 0 / 58

These are the competitors of Genetic Technologies in the industry Diagnostics & Research ranked by linearity 10 years
1. Inotiv NOTV
176.09
2. Guardant Health GH
72.66
3. Neogen NEOG
37.49
4. Ortho Clinical Diagnostics Holdings OCDX
33.4
5. Illumina ILMN
9.49
6. Olink Holding OLK
8.11
7. National Research NRC
6.43
8. CareDx CDNA
6.1
9. Pacific Biosciences of California PACB
6.01
10. DarioHealth DRIO
5.72
11. Global Cord Blood CO
5.67
12. Myriad Genetics MYGN
5.43
13. Fulgent Genetics FLGT
4.11
14. Sotera Health SHC
3.91
15. Qiagen QGEN
3.73
16. Syneos Health SYNH
3.71
17. Co-Diagnostics CODX
3.41
18. Sera Prognostics SERA
3.14
19. Enzo Biochem ENZ
3.05
20. Exact Sciences EXAS
2.98
21. Anixa Biosciences ANIX
2.95
22. Psychemedics PMD
2.94
23. NeoGenomics NEO
2.75
24. Bioventus BVS
2.54
25. Aspira Womens Health AWH
2.28
26. Exagen XGN
2.2
27. MDxHealth MDXH
2.19
28. Meridian Bioscience VIVO
2.1
29. Biodesix BDSX
2.05
30. MaxCyte MXCT
1.98
31. bioAffinity Technologies BIAF
1.91
32. Prenetics Global PRE
1.88
33. Twist Bioscience TWST
1.83
34. Personalis PSNL
1.8
35. Laboratory Corp of America Holdings LH
1.7
36. Organovo Holdings ONVO
1.66
37. Neuronetics STIM
1.65
38. Quest Diagnostics DGX
1.57
39. Trinity Biotech TRIB
1.56
40. SeqLL SQL
1.43
41. Waters WAT
1.23
42. Interpace Biosciences IDXG
1.18
43. PerkinElmer PKI
1.15
44. Precipio PRPO
1.1
45. Charles River Laboratories CRL
1.03
46. Agilent Technologies A
0.91
47. IQVIA Holdings IQV
0.72
48. Thermo Fisher Scientific TMO
0.55
49. Heska HSKA
0.52
50. Mettler-Toledo MTD
0.5
51. Lantheus Holdings LNTH
0.49
52. Danaher DHR
0.47
53. RadNet RDNT
0.42
54. Natera NTRA
0.42
55. IDEXX Laboratories IDXX
0.38
56. Medpace Holdings MEDP
0.38
57. DexCom DXCM
0.36
58. Icon ICLR
0.16

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.